SellYourWay.org Publishes Expert Insights on the Impact of Confidentiality and Transition Planning in Successful Business Sales
INDEPENDENCE, Ohio, Sept. 9, 2025 /PRNewswire/ — Today, SellYourWay.org is pleased to announce the publication of, Beyond the Price Tag: Why Confidentiality... Read more.
ICEYE launches high-performance Gen4 satellite for commercial operations
Gen4 sets a new SAR satellite performance standard, featuring up to 16 cm resolution and an expanded 400 km high-resolution coverage area, enabling more images... Read more.
Bybit Partners with Sygnum to Bring Off-Exchange, Swiss-Regulated Custody to Strengthen Institutional Crypto Security
DUBAI, UAE, Sept. 9, 2025 /PRNewswire/ — Bybit, the world’s second-largest cryptocurrency exchange by trading volume, today announced a strategic partnership... Read more.
BioArctic: Gunilla Osswald awarded Uppsala University Alumnus of the year 2025
STOCKHOLM, Sept. 9, 2025 /PRNewswire/ — Uppsala University announced today that BioArctic AB’s (publ) (NASDAQ STOCKHOLM: BIOA B) CEO, Gunilla Osswald,... Read more.
Mega Matrix Inc. to Participate in H.C. Wainwright 27th Annual Global Investment Conference, Highlighting Stablecoin Governance Token DAT Strategy
SINGAPORE, Sept. 9, 2025 /PRNewswire/ — Mega Matrix Inc. (“MPU” or the “Company”) (NYSE American: MPU), today announced it will participate... Read more.
Star Refrigeration shortlisted for three honours at the Made in Scotland Awards 2025
GLASGOW, United Kingdom, Sept. 9, 2025 /PRNewswire/ — Star Refrigeration has been recognised for its pioneering role in renewable energy, digital innovation... Read more.
DeuterOncology to Present Promising Phase I DO-2 MET Kinase Inhibitor Data at WCLC 2025
DO-2 is a best-in-class MET kinase inhibitor that has completed enrollment in a Phase 1 dose escalation study Tumor shrinkage was observed in 100% of MET exon 14... Read more.
Kling Bio Validates its Proprietary B-Cell Technology for Rapid Response Against Emerging Viral Variants
Study demonstrated the use of immortalized B-cell libraries as a rapid and adaptable approach to therapeutic development against evolving viral threats Discovered... Read more.
Pheon Therapeutics Bolsters Board of Directors with Oncology R&D Expert Dr. Samuel Blackman
Dr. Blackman is an Entrepreneur-in-Residence at Google Ventures and a former senior pharma executive with a track record of leading the development of innovative... Read more.
AMSilk Secures EUR 52M Strategic Financing to Accelerate Commercial Growth
Funding enables AMSilk to scale industrial production and meet global customer demand for biotech produced silk-based protein materials The financing round was led... Read more.